Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2021 | 06-2021 | 05-2021 | 03-2021 | 02-2021 | |
| Operating Expenses | 0 | 2,254 | 2,251 | 1,696 | 1,868 |
| Operating Income | N/A | -2,254 | -2,251 | -1,696 | -1,868 |
| Other Income | 0 | 2 | 2 | 1 | 2 |
| Pre-tax Income | 0 | -2,252 | -2,250 | -1,695 | -1,866 |
| Net Income Continuous | N/A | -2,252 | -2,250 | -1,695 | -1,866 |
| Net Income | $N/A | $-2,252 | $-2,250 | $-1,695 | $-1,866 |
| EPS Basic Total Ops | N/A | -26.98 | -26.98 | -24.29 | -29.68 |
| EPS Basic Continuous Ops | N/A | -26.00 | -26.27 | -23.23 | -29.64 |
| EPS Diluted Total Ops | N/A | -26.98 | -26.98 | -24.29 | -29.68 |
| EPS Diluted Continuous Ops | N/A | -26.00 | -26.27 | -23.23 | -29.64 |
| EBITDA(a) | $N/A | $-2,254 | $-2,251 | $-1,696 | $-1,867 |